Merck & Co. (MRK)
(Delayed Data from NYSE)
$79.29 USD
+1.17 (1.50%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $79.36 +0.07 (0.09%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth B Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, Merck & Co., Inc. has a market cap of $196.16B, which represents its share price of $78.12 multiplied by its outstanding shares number of 2.51B. As a large-cap company, MRK's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
MRK 79.29 +1.17(1.50%)
Will MRK be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MRK based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MRK
MRNA Beats on Q2 Earnings & Sales, Stock Down on Lowered Sales View
Stock Market News for Aug 1, 2025
MRK: What are Zacks experts saying now?
Zacks Private Portfolio Services
Merck Unveils Cost-Cutting Plan: Can it Create Long-Term Value?
Will Collaboration With Bain Capital Help BMY Advance Its Pipeline?
Merck Q2 Earnings Top, Sales Meet Estimates, 2025 View Narrowed
Other News for MRK
5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8.5% (August 2025)
Market Voices: Trump vs. Big Pharma, Swiss tariffs, tariff legality
Trump Trade: Trump signs executive order raising tariff on Canada to 35%
Top 10 High-Yield Dividend Stocks For August 2025
European pharmaceutical stocks slip after Trump pushes for lower drug prices